U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 11 - 11 of 11 results

CANARIUM LUZONICUM WHOLE

MORE DETAILS

5BH1ESR432

structurally diverse
Status:
Possibly Marketed Outside US
Source:
21 CFR 358H
(2014)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3efbb5a6-0a45-47f1-a769-04455256918d
First approved in 2014
Source:
21 CFR 358H
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3efbb5a6-0a45-47f1-a769-04455256918d
Class:
STRUCTURALLY DIVERSE

Showing 11 - 11 of 11 results

NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966